Parathyroid hormone (PTH) measurement is a critical diagnostic tool in the management of chronic kidney disease (CKD) and its associated mineral and bone disorders. Accurate quantification of PTH is ...

TAMPA (BLOOM) – January is Thyroid Awareness Month, and there are thyroid and parathyroid conditions that can severely impact your quality of life and, in some cases, endanger it. However, experts can ...

Secondary hyperparathyroidism is a complex endocrine condition characterized by excess circulating parathyroid hormone (PTH) resulting from an underlying condition, most commonly chronic kidney ...

Medically reviewed by Kelly Wood, MD Endocrine disorders happen when hormone levels are too high or too low. Fatigue and mood ...

AstraZeneca is bolstering its rare disease pipeline with a deal to buy Amolyt Pharma, a biotech company in late-stage development with a therapy designed to treat a rare hormone deficiency whose only ...

(Reuters) -Ascendis Pharma said on Monday the U.S. Food & Drug Administration had approved its therapy to treat adult patients with a hormone disorder, sending the Danish drugmaker's shares more than ...

A new study jointly led by the School of Clinical Medicine at the LKS Faculty of Medicine, of the University of Hong Kong (HKUMed), has found that surgical removal of ...

FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S. (Reuters) -The U.S. Food & Drug Administration has extended its review of ...

Dysparathyroidism, encompassing both hyperparathyroidism and hypoparathyroidism, significantly affects calcium and phosphate ...

While the mechanisms for these associations remain to be elucidated, studies have shown a consistent and independent relationship between increased FGF-23 with markers of CVD, including left ...